Wilson Sonsini Goodrich & Rosati represented 6 Dimensions and VFLO in this transaction. Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Boyu Capital in the transaction. The Longreach Group announced that it had, together with the founder family minority shareholders, completed...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised RTW Investments on the deal. Oricell Therapeutics Co., Ltd, a China-based innovative pharmaceutical company committed to the development of tumor...
You must be a Standard 1 Year member to access this content.
YPOG, Held Jaguttis, King & Spalding, KNPZ , Pusch Wahlig and Wilson Sonsini Goodrich & Rosati advised Wallaby Medical on the deal. Skadden, Arps, Slate, Meagher...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised InSilico Medicine on the deal. Ashurst represented Mirae Asset Capital. Hong Kong-based InSilico Medicine, a global leader in end-to-end artificial...
You must be a Standard 1 Year member to access this content.
